Original news and analysis on international IP policy
A recent lawsuit involving patents on human genes related to cancer brought against the United States patent office, a biotechnology company and a foundation has attracted international attention to the issue of gene patenting, and on 27 August a group of influential associations voiced their opposition to such patents.
Scientists and bureaucrats meeting this week on climate change and weather data are struggling to move global discussion past general declarations of recognition and commitment to address environmental change. One bump under the rug at the United Nations conference is rights over environmental technologies, and a new UN report released Tuesday calls for investment and a focus on flexibilities in and possible changes to intellectual property rights rules to help developing countries access information and technologies.
Google’s settlement in the United States of copyright infringement claims by authors and book publishers faces strong opposition from European publishers. The deal does not apply to books outside the US and one Google official has suggested the need for a similar service in Europe. Could digital library Europeana be the solution? A 28 August European Commission policy statement addressed that concern and others.
Authorities in the European Union and the United States have recently taken a tougher stance against reverse payments - patent settlements whereby, according to many competition experts, dominant drug companies buy off potential rivals.
The Development Agenda at the World Intellectual Property Organization is a “potentially revolutionary” agreement, according to a book released this month, but whether it will fulfil that promise depends on its implementation into concrete practice, said a panel of academics at the book’s launch.
The United Nations Economic and Social Council, a key coordinating body meeting this summer in Geneva, is considering ways to move nations faster toward global public health goals, with a warning from developing countries that intellectual property rights should not interfere with access to medical products and innovation.
A conference aimed at sketching out ideas for the World Intellectual Property Organization’s involvement in issues of global public policy kicked off Monday with explorations on the link intellectual property and environmental technology and a separate event devoted to access to reading material for the visually impaired.
COPENHAGEN – Windupbird Publishing owned by Swedish author Fredrik Colting, alias John David California, promises that its books will “tickle your feet and yank your soul.” But American author J.D. Salinger is not amused and has indeed been wound up by Colting's latest book, which he says is infringing on the copyright of his best-seller, "Catcher in the Rye." A New York court recently sided with Salinger, but Intellectual Property Watch talked to Colting about why the battle is bound to go on.
Pharmaceutical companies are manipulating the intellectual property rights system and are “actively trying to delay the entry of generic medicines onto their markets,” a top EU official said of an EU inquiry into the pharmaceutical sector released Wednesday. As a result, there has been a decline in the number of innovative medicines getting to the market, it says.
With three important processes coming to a head at the Internet Corporation for Assigned Names and Numbers (ICANN) this year, it is difficult not to overlook some changes in the private body, which oversees the internet domain name system. At ICANN's recent board meeting, the appointment of a shiny new CEO, former United States Homeland Security Department cybersecurity director Rod Beckstrom, drew attention away from top issues, which include the introduction of new top-level domains, ongoing institutional reform, and the looming September expiration of the ICANN-US government agreement.